Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis

B Langdahl, S Ferrari… - Therapeutic advances in …, 2016 - journals.sagepub.com
The adult skeleton is renewed by remodeling throughout life. Bone remodeling is a process
where osteoclasts and osteoblasts work sequentially in the same bone remodeling unit …

Primary hyperparathyroidism

MD Walker, SJ Silverberg - Nature Reviews Endocrinology, 2018 - nature.com
In this Review, we describe the pathogenesis, diagnosis and management of primary
hyperparathyroidism (PHPT), with a focus on recent advances in the field. PHPT is a …

[HTML][HTML] Irisin mediates effects on bone and fat via αV integrin receptors

H Kim, CD Wrann, M Jedrychowski, S Vidoni, Y Kitase… - Cell, 2018 - cell.com
Irisin is secreted by muscle, increases with exercise, and mediates certain favorable effects
of physical activity. In particular, irisin has been shown to have beneficial effects in adipose …

Parathyroid hormone directs bone marrow mesenchymal cell fate

Y Fan, J Hanai, PT Le, R Bi, D Maridas, V DeMambro… - Cell metabolism, 2017 - cell.com
Intermittent PTH administration builds bone mass and prevents fractures, but its mechanism
of action is unclear. We genetically deleted the PTH/PTHrP receptor (PTH1R) in …

Biomimetic delivery of signals for bone tissue engineering

M Dang, L Saunders, X Niu, Y Fan, PX Ma - Bone research, 2018 - nature.com
Bone tissue engineering is an exciting approach to directly repair bone defects or engineer
bone tissue for transplantation. Biomaterials play a pivotal role in providing a template and …

[HTML][HTML] Bone composition: relationship to bone fragility and antiosteoporotic drug effects

AL Boskey - BoneKEy reports, 2013 - ncbi.nlm.nih.gov
The composition of a bone can be described in terms of the mineral phase, hydroxyapatite,
the organic phase, which consists of collagen type I, noncollagenous proteins, other …

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

DM Black, SL Greenspan, KE Ensrud… - … England Journal of …, 2003 - Mass Medical Soc
Background Parathyroid hormone increases bone strength primarily by stimulating bone
formation, whereas antiresorptive drugs reduce bone resorption. We conducted a …

Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial

KG Saag, JR Zanchetta, JP Devogelaer… - … : Official Journal of …, 2009 - Wiley Online Library
Objective To compare the bone anabolic drug teriparatide (20 μg/day) with the antiresorptive
drug alendronate (10 mg/day) for treating glucocorticoid‐induced osteoporosis (OP) …

[BUCH][B] Microcomputed tomography: methodology and applications

SR Stock - 2019 - taylorfrancis.com
MicroComputed Tomography has become the gold standard for studying 3D microscopic
structures nondestructively, and this book provides up-to-date coverage of the modality. The …

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use

AB Hodsman, DC Bauer, DW Dempster… - Endocrine …, 2005 - academic.oup.com
All therapies currently recommended for the management of osteoporosis act mainly to
inhibit bone resorption and reduce bone remodeling. PTH and its analog, teriparatide …